The chemical class known as C1orf69 Activators encompasses a specialized group of compounds identified for their ability to modulate the activity of the C1orf69 gene. C1orf69, or Chromosome 1 Open Reading Frame 69, is a gene encoding a protein whose precise function remains largely unknown. Despite this, computational analyses and bioinformatics suggest potential involvement in various cellular processes, such as cell signaling, protein-protein interactions, or intracellular transport. Activators of C1orf69 are substances capable of enhancing the expression or function of this gene, potentially influencing downstream cellular pathways and biological responses associated with its activity.
Characterizing compounds as C1orf69 Activators typically involves comprehensive screening processes aimed at evaluating their ability to interact with regulatory elements of the C1orf69 gene or modulate the activity of proteins associated with its expression or function. These activators may operate through diverse mechanisms, including binding to specific DNA sequences within the gene promoter region, regulating the activity of transcription factors responsible for C1orf69 gene expression, or modulating post-translational modifications of the C1orf69 protein. Understanding the molecular mechanisms underlying C1orf69 activation by these compounds is crucial for elucidating the roles of C1orf69 in cellular physiology and function. Further research into C1orf69 Activators may provide insights into novel cellular pathways and contribute to a deeper understanding of C1orf69's function in cellular homeostasis and signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, a component of the ERK/MAPK pathway, potentially impacting transcription factors and gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could alter AKT signaling and potentially affect downstream transcriptional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAPK, potentially affecting transcription factors and regulators associated with stress response genes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may modulate AP-1 transcription factor activity and subsequent gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling, which can have broad effects on transcriptional regulation and protein synthesis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor, which could indirectly influence gene expression by altering ERK/MAPK pathway activity. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
An inhibitor of histone methyltransferase G9a, potentially affecting chromatin structure and gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, potentially leading to DNA demethylation and altered gene expression profiles. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A selective G9a/GLP histone methyltransferase inhibitor, potentially affecting the epigenetic state of genes and their expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor that could result in DNA demethylation and affect gene expression. | ||||||